Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Account Payables: 2014-2020

Historic Change in Account Payables for Fortress Biotech (FBIO) over the last 2 years, with Dec 2020 value amounting to -$19,000.

  • Fortress Biotech's Change in Account Payables was N/A to -$19,000 in Q4 2020 from the same period last year, while for Dec 2020 it was -$288,000, marking a year-over-year change of. This contributed to the annual value of -$149,000 for FY2019, which is 547.83% down from last year.
  • Fortress Biotech's Change in Account Payables amounted to -$19,000 in Q4 2020, which was down 246.15% from $13,000 recorded in Q1 2020.
  • In the past 5 years, Fortress Biotech's Change in Account Payables ranged from a high of $133,000 in Q1 2019 and a low of -$298,000 during Q3 2019.
  • For the 3-year period, Fortress Biotech's Change in Account Payables averaged around -$19,778, with its median value being -$1,000 (2018).
  • The largest annual percentage gain for Fortress Biotech's Change in Account Payables in the last 5 years was 1,700.00% (2019), contrasted with its biggest fall of 472.50% (2019).
  • Over the past 4 years, Fortress Biotech's Change in Account Payables (Quarterly) stood at $24,000 in 2017, then slumped by 104.17% to -$4,000 in 2018, then plummeted by 472.50% to -$298,000 in 2019, then tumbled by 90.23% to -$19,000 in 2020.
  • Its last three reported values are -$19,000 in Q4 2020, $13,000 for Q1 2020, and -$298,000 during Q3 2019.